Structure Therapeutics (GPCR) Shares Outstanding (2022 - 2026)

Structure Therapeutics' Shares Outstanding (Entity) history runs 5 years deep, the most recent figure standing at $213.2 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) rose 23.52% year-over-year to $213.2 million; the TTM figure through Mar 2026 stood at $213.2 million (up 23.52% YoY), while the FY2025 annual figure was $212.5 million, up 23.65% from the prior year.
• Shares Outstanding (Entity) for Q1 2026 stood at $213.2 million, roughly flat from $212.5 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $213.2 million in Q1 2026, with the low at $10.5 million in Q2 2022.
• The 5-year median for Shares Outstanding (Entity) is $139.9 million (2024), against an average of $127.6 million.
• The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) jumped 927.43% in 2023, then grew 0.65% in 2025.
• Structure Therapeutics' Shares Outstanding (Entity) stood at $75.1 million in 2022, then soared by 46.8% to $110.2 million in 2023, then soared by 55.96% to $171.9 million in 2024, then grew by 23.65% to $212.5 million in 2025, then gained by 0.33% to $213.2 million in 2026.
• Business Quant data shows GPCR's Shares Outstanding (Entity) at $213.2 million in Q1 2026, $212.5 million in Q4 2025, and $182.0 million in Q3 2025.